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Abstract
Many diseases are believed to be related to abnormal protein folding. In the first step of such pathogenic structural
changes, misfolding occurs in regions important for the stability of the native structure. This destabilizes the normal protein
conformation, while exposing the previously hidden aggregation-prone regions, leading to subsequent errors in the folding
pathway. Sites involved in this first stage can be deemed switch regions of the protein, and can represent perfect binding
targets for drugs to block the abnormal folding pathway and prevent pathogenic conformational changes. In this study, a
prediction algorithm for the switch regions responsible for the start of pathogenic structural changes is introduced. With an
accuracy of 94%, this algorithm can successfully find short segments covering sites significant in triggering conformational
diseases (CDs) and is the first that can predict switch regions for various CDs. To illustrate its effectiveness in dealing with
urgent public health problems, the reason of the increased pathogenicity of H5N1 influenza virus is analyzed; the
mechanisms of the pandemic swine-origin 2009 A(H1N1) influenza virus in overcoming species barriers and in infecting
large number of potential patients are also suggested. It is shown that the algorithm is a potential tool useful in the study of
the pathology of CDs because: (1) it can identify the origin of pathogenic structural conversion with high sensitivity and
specificity, and (2) it provides an ideal target for clinical treatment.
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Introduction
Protein folding is a natural process wherein proteins undergo
self-assembly through ‘‘folding’’ of their polypeptides into
characteristic functional structures. At times, proteins fail to fold
into their correct forms. When incorrectly folded proteins
accumulate, they clump together; this is believed to be the cause
of conformational diseases (CDs) such as Alzheimer’s disease.
Since the structure of a protein is the foundation of its biological
function, such misfolding can either induce a disease-related error
in performing the natural bio-function of an endogenous protein
or produce a novel type of infection that is unfamiliar to the
immune system. A well-known example for the former is the
transmissible spongiform encephalopathy (TSE), a group of fatal
neurodegenerative diseases caused by misfolding of the prion
protein (PrP) [1,2,3]. The avian influenza virus [4] and A(H1N1)
flu outbreak in April 2009 [5] are typical examples for the latter.
Therefore, CDs are not rare, but are responsible for the
development of wide range of diseases. Protein aggregation(i.e.,
amyloid deposition in tissues) is one of the typical features of many
endogenous CDs. The aggregation-prone regions determine the
tendency of proteins to aggregate and form amyloid fibrils [6,7].
Such ‘‘hot spots’’ of fibril formation are usually abundant. As too
many candidate target sites are involved, it is noisy and
inappropriate for clinical treatment (e.g., in Figure 1E, half sites
are in amyloid core of PrP). On the other hand, investigations
conducted on such hot spots have mainly focused on the second
stage of aggregation. The aggregation-prone regions tend to be
blocked in the native state [8]. For an in-depth investigation on
amyloid formation, the initial stage of the exposure of the hot
spots, namely the unlocking mechanism in nosogenetic misfolding,
should be the focus. The corresponding site is like a switch where
the sensitive regions of the native structure begin to be exposed.
Once identified, switch regions can be ideal targets for clinical
treatment if they are not active sites. Moreover, for exogenous
cases, such sites are also significant in identifying the pathology of
a novel type of infection. Thus, there is a need to identify regions
that are significant for the ‘disease-related’ stability of proteins.
In the last decade, protein stability has been of wide interest as a
fairly mature subject. However, it still has much left to offer for the
investigation of the nature of CDs. CDs are an evolutionary
phenomenon that involve both protein misfolding and evolution.
Prediction algorithms such as CUPSAT [9] can easily confirm that
many sites are important for protein stability (accuracy *85%,
e.g. Figure 1E.). However, after hundreds of million years of
evolution, many unstable protein mutants have been inhibited or
forbidden by the selection pressure of evolution, and thus do not
exist in the present CDs. Although unstable mutants can be
predicted accurately, without the aid of evolutionary information,
the importance of such variants may be estimated falsely, and too
many candidate target sites would make clinical treatment difficult
as well. Therefore, both evolutionary information and molecular
stability must be considered in dealing with such an interdisci-
plinary subject.
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8441Many proteins are involved in CDs. Some have been identified
by clinical analysis, but there are also many unknown but
suspected cases. As a prerequisite for in-depth research, clinical
information directs the studies on CDs. While the clinical
information is not sufficient because it requires sophisticated
techniques and manipulations, it is difficult to be obtained even in
countries with a high degree of medical expertise. Due to such
restrictions, it was beyond the scope of the previous technical line
to perform a systematic study of CDs. However, an accurate
prediction of switch regions would cause advancement in
systematic studies. For example, if a mutation occurs in a
predicted switch region, then there is a considerable opportunity
for a CD to develop. The scope of in-depth research could thus be
usefully increased. Moreover, based on the predicted switch
regions, we could evaluate the risk level of a candidate CD,
determine the target sites for treatment, and then fix the protein in
a stable conformation, overcoming the need for a complex and
unnecessary analysis of the morbid conformation, and this would
optimize clinical treatment.
In a previous study, we have treated proteins as successive
overlapping short residue segments, and have presented a graph of
polypeptide relationship (GPR) [10]. The aim of that study was to
identify detailed topological features of homologous relationships
for short residue segments in the whole universe of non-membrane
proteins. To construct a nonredundant graph, a data set composed
of proteins that exhibit low sequence identity of less than 25% was
analyzed. Short polypeptides were treated as nodes of a network.
Remote homologous polypeptides were grouped together and
connected by edges(see Appendix S1, About the graph of
polypeptide relationship, GPR). As shown in Figure 2, the
selection pressure of evolution has impressed distinct fingerprints
in the universe of polypeptides, with the following features:
1. The polypeptide phase space is composed almost entirely of
two nearly separated regions, a helix-donut zone and a strand-
arc zone. The helix-donut zone consists of helix segments and
N/C-terminal helix caps, while the latter is mainly comprised
of b-sheet segments and N/C-terminal strand caps.
2. The two parts are connected flimsily by sparse edges. Donors of
these edges bridge the two zones.
As bridge nodes connect the two major regions, there should be
a certain probability for these segments to be in one state, and a
Figure 1. Results for human prion (PDB ID 1qm2_A, 104
residues in length). (A) Structure of prion in cartoon form. It has been
reported that sites in bonds (159 blue, 189 magenta, 192 yellow, 194
olive, and 196 green) are important in hampering pathogenic changes
in the prion. (B) Binding pocket for anti-prion compound GN8, overlaid
in green [11]. (C) Interchange probability for each 15-residue segment
indexed by its central residue. In our analysis, each residue is covered by
at most 15 successive segments. To evaluate the significance of each
residue site, we scored the interchange probability per site using the
maximum interchange probability for the corresponding 15 polypep-
tides. The interchange probability for each residue site is shown in D. In
A and D, the switch regions predicted are shown in red. (E) Significance
per site for the stability of the prion predicted in the absence of
evolutional information. Every type of point mutation is presumed for
each residue in the prion protein, that is, 104|19 variants in total. The
overall stability of each type of mutant was predicted using the CUPSAT
algorithm [9]. The number of destabilizing mutants are reported per
site. Residues in the core of the prion amyloid identified by site-directed
spin labelling and EPR spectroscopy [13] are also shown.
doi:10.1371/journal.pone.0008441.g001
Figure 2. Sketch map of the topological features of homolo-
gous relationships for short residue segments in the whole
universe of non-membrane proteins. The universe of non-
membrane polypeptide is composed almost entirely of two nearly
separated regions, a helix-donut zone and a strand-arc zone. The helix-
donut zone consists of helix segments and N/C-terminal helix caps,
while the latter is mainly comprised of b-sheet segments and N/
Cterminal strand caps. Two major regions are sparsely connected by
bridge nodes that favor both types of folding, and can thus potentially
cause conformational conversion. Insert: Donut-shaped fingerprint
formed by vital nodes/polypeptides of the graph of polypeptide
relationships (GPR) [10].
doi:10.1371/journal.pone.0008441.g002
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they have a double aspect, that is, a potential to cause
conformational conversion. It means that both requirements are
satisfied by the knowledge system because there are distinct
structural differences between a helix and a strand, and the
evolutionary information on remote homologues has been
considered for the construction of GPR. It is rational to investigate
CD based on knowledge of the GPR.
In the present study, we used topological information from the
GPR to predict switch regions responsible for the pathogenic
structural changes. The algorithm was applied to most classical
proteins responsible for diverse CDs. The results show that the
algorithm is efficient and robust, and the predictions are consistent
with clinical reports. To the best of our knowledge, this is the first
accurate algorithm that can predict a number of CDs. Moreover,
we analyzed protein NS1 of the H5N1 influenza virus, and found
that local structural change is one mechanism responsible for the
high pathogenicity and virulence of the H5N1 influenza virus. As a
response to a recent outbreak, we also provided both theoretical
and experimental evidence to illustrate the mechanism of the
A(H1N1)/2009 influenza virus in overcoming species barrier as a
result of a local structural change in its nucleoprotein. Moreover,
the absence of immunological response to the switch region is
responsible for the large number of potential patients and a high
ratio of young sufferers.
Results
We treated protein as successive overlapping short residue
segments. For each residue segment, we evaluated its ability to
develop pathogenic structural change by its probability to jump
from the native helix-donut/strand-arc state to the other state.
Segments with a high interchange probability are predicted to be
switch regions. As illustrated in Methods, the algorithm is an
inborn cross-validation for any query protein. A protein is
predicted based on knowledge independent of itself.
Conformational change is a general disease related phenome-
non. Some cases are classified as classical CD proteins due to the
notable structural changes. There are also numerous disease-
related proteins that are not classified as CD proteins but can be
investigated in the context of CDs. It is difficult to identify proteins
that are not associated with CD. Thus we tested the algorithm
with the well-studied classical CD proteins and identified regions
that cover the sites significant for initial pathogenic structural
changes.
Since it is based on the knowledge of non-membrane proteins,
the algorithm was designed for proteins in body fluids(PBF,
proteins in both extracellular and intracellular fluids are involved.).
The majority of the 31 disease-related proteins listed in refs
[3,14,15,16,17] belong to this protein type. Among them,
seventeen PBFs have usable protein structures, can be treated
with the algorithm(see Appendix S1, About testing set). As an
example, we report the detailed results for the prion. Results for
the 16 other proteins are reported in the Appendix S1.
In 2007, Kuwata et al. [11] reported that the intercalation of an
anti-prion compound GN8 to the region N159-V189-T192-K194-
E196 could inhibit the pathogenic change process of the prion.
The five sites should be significant in triggering conformational
conversion, that is, they should act as switches for the PrP. We
evaluated the interchange probability for each 15-residue
polypeptide of human PrP. As shown in Figure 1C, a peak for
the interchange probability occurs in the window with central site
195. Thus, sites 188–202 should be responsible for the origin of the
conformational changes. Four out of the five aforementioned
switch sites are within this region. Moreover, as shown in
Figures 1A and 1B, compared with the functional area reported
by Kuwata, we found that the predicted switch region corre-
sponded exactly to the main body of the binding pocket for GN8,
which means our prediction is quite accurate.
Switch region is a concept based on clinical cases that come
forth under the selection pressure of evolution and that actually
occur in life. It is not appropriate to define switch regions using
information on artificial unstable mutants, in which evolutionary
pressure is neglected. Therefore, data from experiments on point
mutations were not considered in identifying switch regions.
Different from fibril-forming hot spots that are usually identified
by observing the core of amyloid fibrils, we identified initial sites of
conformational changes through reports in which a switch role is
evident, such as experiments to inhibit the pathogenic change
process (prion) and disease-related point mutations observed in
clinical practice. For some proteins, there are many residue sites
where disease-related mutations can be clinically observed, that is,
where disease is induced. If a region is significant for the initiation
of pathogenic structural conversion, the density of this disease-
related site should be high. Consequently, it is rational to define a
switch region as a segment with the highest density of disease-
related sites. In this way, we were able to identify switch regions for
low-density lipoprotein, cystic fibrosis transmembrane conduc-
tance regulator, apolipoprotein AI, fibrillin-1, superoxide dismu-
tase, crystallins, and hemoglobin (see reference in Table 1). There
are too many such sites for hemoglobin, and the differences in
density are not obvious. Thus, only sites corresponding to highly
unstable disease-related mutants were used in the identification for
hemoglobin. For the other proteins, the identification was easier
and less controversial. There is ample credible proof in the
literature that is widely accepted for each switch region we have
defined. The diversity in identifying switch regions exhibits the
variety in biology.
We predicted the potential switch region in CDs proteins and
found that they could map to actual switches very well. For low-
density lipoprotein and cystic fibrosis transmembrane conductance
regulator, the corresponding motifs extend out into the body
fluids, aiming at the molecules therein. These modules work far
from the membrane, largely in a non-membrane-like environ-
ment, therefore they can also be treated by the algorithm. As
shown in part one of Table 1, for proteins in body fluid or motifs
extending out into the body fluids, there is evidence of the key
contributions in initiating pathogenic structural changes for most
of the predicted switch regions. The prediction results and clinical
reports are in very good agreement. Aside from the neutral
prediction for the extremely complicated tumor suppressor p53, 16
out of the 17 proteins are correctly predicted, with a success rate
(sensitivity and specificity) of approximately 94%. There are a total
of 2649 residues in the 17 proteins, in which a small proportion
(302 residues, 11.4%) was predicted as residues in the switch
regions. Therefore, the algorithm is highly sensitive and specific for
the region of switch/true signal.
To clarify the available range of this algorithm, we show the
results of the proteins that fit poorly in the second part of Table 1,
wherein the limitation is shown by the predictions especially in
branch-chain a-ketoacid dehydrogenase complex and b-hexosa-
minidase. These proteins either interact tightly with the membrane
or aim at the molecules on the membrane, namely they have
significant interactions with the membrane environment. There-
fore, the knowledge system of the present algorithm is unsuitable,
resulting in unsatisfactory predictions.
The purpose of the algorithm is to identify the riskiest region of a
protein, and to construct a foundation for further investigation.
Conformational Disease Switch
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Protein Disease PDB ID chain Predicted region Prediction accuracy and proof [reference]
Proteins in body fluid
Insulin Injection-localized
amyloidosis
1AI0_A 6–20
.000000000
IP=0.0019
Accurate. Nativedisulfidebondscontributedbythecysteinesinregion
6–20 are retained in fibril, providing substantial constraints to refolding.
The corresponding segment plays a significant role in forming initial
aggregates of insulin amyloid, i.e. a switch region [29]
Prion Creutzfeldt-Jakob & kuru
disease in humans
1QM2_A 188–202
.000000000
IP=0.0036
Accurate. Intercalation of anti-prion compound GN8 to region N159-
V189-T192-K194-E196can hamper thepathogenic structuralconversion
process [11]. This indicates thatsites 189,192,194 and196 arethe kernel
of the switch region for prion.
Apolipopro-tein AI Familial amy-loid polyneuro-
pathy, visceral amyloid
2A01_A 1–15
.000000000
IP=0.046
Correct. Helices A:1-43 govern the structural stability of lipid-free Apo-
AI [30]. In these helices, some point mutations at sites 3,10,13, and 26
result in various clinical consequences [31]. Among these sites, three of
four are in the region we predict.
Calcitonin Ct Medullary carcinoma of the
thyroid
1BYV_A 16–31
.000000000
IP=0.058
Correct. Segment 15–21, especially residues 18 & 19 governs fibril
formation and the biochemical properties of human calcitonin
[32,33].Joint mutations Y12L-N17H-A26N-I27T-A31T [34] hamper
pathogenic refolding, resulting in non-amyloidogenic analogues of
human Ct.
Cystatin C Hereditary cerebral
angiopathy
1G96_A 61–74
.000000000
IP=0.073
Correct. According to clinical reports, the most important mutation is
at 68 Leu?Gln, which is associated with a severe conformational
disease and causes massive amyloidosis, cerebral hemorrhage and
death in young adults [35,36]
Hemoglobin Severe hemolytic anemia 1XZ2_B 99–125
..00000000
IP=0.14
Correct. In all point mutations related to hemolytic anemia there are
four highly unstable variants (V60E, L110P, A115D, Q127R). Three of
these are in or close to the region we predict. This means that the
predictedregionissignificantforthestabilityofthehemoglobinb-chain
[37].
Gelsolin Finnish hereditary systemic
amyloidosis
1RGI_G 243–264
...0000000
IP=0.21
Accurate. Amyloidogenesis of plasma gelsolin is triggered by
metalloendoprotease cleavage. In aberrant endoproteolytic release of
amyloidogenic fragments, the cleavage site is either A242–M243 or
M243–L244 [38].
Lysozyme Familial visceral amyloidosis 1W08_A 41–57
...0000000
IP=0.22
Correct. According to [39], structural rearrangement in region 45–51 is
small in ordinary mutants, but very strong in disease-related variants.
Consequently,sites 45–51 should be a switch region forlysozyme. These
sites are within the region we predict.
Fibrillin-1 Marfan syndrome 1EMN_A 2146–2164
....000000
IP=0.33
Correct. In the motif, there are three sites(D2127, N2144, C2151) for
which marfan syndrome related point mutations have been reported
[40]. Two of them coincides with our prediction.
b micro-globulin Hemodialysis amyloidosis 2VB5_A 7–23
.....00000
IP=0.47
Correct. Connected to the predicted region, 21–31 is the amyloido-
genic core fragment of b2 microglobulin [41,42,43]. Acidification, e.g. at
site 17(N?D ), is necessary for amyloid fibril formation from both wild-
type b2 microglonulin and its variants [44].
Superoxide dismutase,
SOD
Amyotrophic lateral sclerosis 2C9V_A 30–46
.......000
IP=0.66
Correct. There are a total of 26 residue sites for which disease-related
point mutations have been reported [45]. Segment 37–48 is the region
with the highest density of these 26 residue sites. The ratio of site
density between this and the next top region is 3:2.
Transthyretin TTR Familial amyloid neuropathy 1DVQ_A 46–69
........00
IP=0.72
Correct. L55P is the most notorious mutant, with onset of clinical
disease at about 20 years of age [46].In comparison, the age of onset is
about30forV30Mcarriersand80forwild-typesubjects.More-over,site
55 is important in the pathway for TTR polymerization to amyloid fibrils
[47].
p53 tumor suppressor
protein
Various cancers 2FEJ_A 191–205
........00
IP=0.78
Qualitatively correct. Most cancer mutations are located in the DNA-
binding core. Thus, the N-terminal half (residuesw195) is important in
conserving p 53 activity [48,49]. In agreement, we predict higher
interchange probability for the N-terminus. While highly destabilizing
mutants are interspersed along the sequence. There should be several
switchregionsinp53[50].Ourbasicone-switchhypothesiscannot cope
with such extremely complicated case.
Serpins Antithrombin deficiency
thromboem- bolic disease
1E04_A 372–386
.........0
IP=0.87
Correct. Thepredicted region is on theN-terminus ofthereactiveloop
that is vital for the biological properties of serpins, e.g. a1–antitrypsin.
Site 381 plays an important role in stabilizing native, inserted, and
activated states of serpins [51].
Crystallins Cataracts 1HK0_X 14–36
.........0
IP=0.88
Correct. There are five residue sites for which mutants associated with
congenital cataracts have been reported, three of which are in the
region we predict. Substitution P23T is reported as the cause of pivotal
local conformational and dynamic differences [52]
Conformational Disease Switch
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found that the sites tightly related to CD are abundant in the region
we predicted. In thetest setof the 17 proteins, 85 residuesaretightly
associated with CDs. About 52.9% (45) of them are in the region
predicted. In the 302 residues involved in the switch regions
predicted, 14.9% of them have been proven to be tightly disease
associated. Whereas, for those not in the switch regions predicted,
only 1.7% of the residues are tightly associated with CDs.
Interchange probability is a numerical measure of the incidence
of a disease in terms of knowledge of protein evolution. As shown
in the first part of Table 1, cases with low interchange probabilities
in the switch regions are highly fatal (expect injection-localized
amyloidosis, which does not exist in nature and is induced
artificially). For cases involving prions, cystatin C, and hemoglo-
bin, patients who do not undergo clinical treatment usually die at a
very young age, without having the opportunity to transmit their
genes to their offspring. These endogenous proteins are abun-
dantly expressed in vital tissues. Because of the high risk, they must
remain very stable. Protein evolution ensures such stability
through low interchange probability. However, once misfolding
occurs, the result can be fatal. This may be one of the mechanisms
by which nature controls life through evolution.
Discussion
We have presented an algorithm for predicting switch sites in
pathogenic structural changes in CD. As our algorithm is not
sensitive to individual variants, the corresponding therapeutic
regimes should be suitable for most patients. Moreover, as it
approximately characterizes the incidence of a disease regarding
evolution, interchange probability can surely be used to identify
proteins related to CD. This will be published elsewhere.
The success of this study is due to the high accuracy in identifying
remote homologous relationships. It ensures correctness in
calculating interchange probability. In 2008, we found that, in a
protein family, the intramolecular hydrophobic force network of
each member/protein has some common, family representative
features by which a model of family representative hydrophobic
force network can be constructed. According to this model, new
remote members (with sequence identity no more than 30%) of a
protein family can be designed computationally, together with
family representative biochemical properties. At least 80% of the
remote members designed have similar bio-activities with wild-type
proteins (to be published elsewhere). According to such computa-
tional designingand experimentation, it was shown that this model/
theory has caught some evidence for protein evolution [12]. The
present work adopts this model, gaining great improvement in the
quality of remote homologue identification [10,18].
The high success ratio makes the present algorithm a powerful
tool for use in cases that lack clinical reports. As an example, we
present several clues for the study of the highly pathogenic H5N1
influenza virus. The non-structural protein NS1 was suggested to
be associated with the increased pathogenicity and virulence of
these strains. NS1 consists of two domains, a helix-rich double-
stranded RNA binding domain (RBD) and the b-sheet-rich
effector domain (ED), separated through a linker. It is an
Protein Disease PDB ID chain Predicted region Prediction accuracy and proof [reference]
Domain of membrane protein extends out into body fluid
Low-density lipoprotein
receptor
Familial hyper-cholesterolemia,
premature heart disease
1AJJ_A 25–39
.000000000
IP=0.0094
Correct. There are eight residue sites for which disease–related point
mutations havebeen observed. Six ofthem are in theregion wepredict
[53]. This is thus the most important region for initiation of pathogenic
structural conversion.
Cystic fibrosis
transmembrane
conductance regulator
CFTR
Cystic fibrosis 1XMI_A 546–561
..00000000
IP=0.11
Correct. According to the cystic fibrosis mutation database [54],
segment 542–560 is the region with the highest density of missense
mutations responsible for cystic fibrosis. The ratio of site density
between this and the next top region is 2:1.
Membrane proteins
Amyloid-b precursor
protein APP
Alzheimer’s disease 1Z0Q_A 699–713
.000000000
IP=0.0026
Qualitatively correct. Most pathogenic residue mutations occur in
region 692–724,wherethetoptwo high density zones are713–717and
692–694 [55]. The predicted region coincides with such clinical reports.
Since thestructural data endupatA713,andall theseregionsembed in
membrane [56],the prediction is not quite accurate.
Membrane-associated proteins
a-synuclein Parkinson’s disease PD 1XQ8_A 89–124
...0000000
IP=0.25
Maybe correct. Three missense mutations(A30P, A53T and E46K) are
associated with familial PD [57]. While most PD patients carry wild-type
a-synuclein.Therefore PD might be triggered at other sites. As a hotspot
of recent research,the a-synuclein-membrane interaction was found to
affect bilayer structure,stability, and fibril formation [58]. Both N- and C-
terminals of a-synuclein are tightly associated with membrane [59],
important. #89-124 belongs to the C-terminal region.
Branch-chain a-ketoacid
dehydrogenase complex
BCKD
Marple syrup urine disease
MSUD
1U5B_A 146–160
.......000
IP=0.68
Wrong. Branched-chain keto acid dehydrogenase is a multienzyme
complex associated withthe inner membraneof mitochondria.There are
five disease-related point mutations [60]. None of them belongs to the
region predicted.
b-hexosaminidase Tay-Sachs disease 2GJX_A 95–109
.........0
IP=0.87
Wrong. b-hexosaminidase is one part of a complex that degrades the
lipid GM2 ganglioside.The malfunction of its a-subunit brings the ac-
cumulation of GM2 ganglioside in lysosomes, then a neurons damage.
None of 51 pathogenic point mutations [61] is in the region predicted.
Interchange probabilities(IP) for the switch regions predicted are also listed, with sketch maps increasing 0.1 per ‘.’.
doi:10.1371/journal.pone.0008441.t001
Table 1. Cont.
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Sixty percent of human deaths in an outbreak in Vietnam were
related to the NS1 from an H5N1 strain (A/Vietnam/1203/
2004). It was claimed that, instead of distinct dimeric units formed
by ordinary NS1, H5N1 NS1 forms a molecule chain (Figure 3A),
which assembles into three-chain tunnel consequently, resulting in
a fatal mechanism that resists antiviral interferon response [4].
This is due to a significant large-scale structural alteration of the
ED (Figure 3B). For the key mechanism of the formation of the
NS1 chain, several possibilities have been proposed focusing on
the dimeric interface of the H5N1 NS1 ED, the formation of the
RBD dimer, and the length of the linker, respectively.
According to our analysis, the region most important for the
structural change of H5N1 NS1 focused around the resides near
R135(#128-143; Figure 3C, D). Compared with the structure of
H1N1 NS1 ED (a low pathogenic case), this segment has the most
striking structural rearrangement(Figure 3E). Such structural
rearrangement results in the formation of a new RBD binding
sites. Accordingly, NS1 chain with alternating RBD and ED
dimers is formed when the RBD and ED of each NS1 molecule
interact with their respective domains from nearby NS1 molecules
(Figure 3A). This is induced by the structural rearrangement of the
residues around H5N1 NS1 ED R135 that creates the binding
sites. More significantly, the maximum interchange probability is
high, which is 0.46 for H5N1 NS1 protein(Figure 3D). In an
evolutionary aspect, there is a remarkable opportunity for other
highly pathogenic variants to emerge due to the conformational
conversion around R135, that is, inducing more health-related
problems. We suggest this region to be further studied.
Since its emergence in April 2009, the A(H1N1) virus has raised
significant global health concerns. Although many people in public
health organizations have been mobilized around the world, the
trend of this pandemic is much powerful. After about 7 months,
over 503536 people were already infected with at least 6260
deaths(13 Nov 2009). The most dangerous feature of this ‘‘triple
reassortant’’ virus (a hodgepodge of North American swine, avian,
and Eurasian swine flu virus) is that the strain has overcome the
species barrier, this makes humans a reservoir of the virus too. As
it has spread throughout the world, billions of people are at risk.
The RNA segment 5 of the influenza A virus encodes
nucleoprotein (NP), which binds to the viral RNA and can be
packaged into ribonucleoproteins (RNPs). NPs, along with three
polymerase proteins, PB1, PB2, and PA, play important roles in
the viral replication life cycle. NPs also function as a key adapter
molecule between virus and host cell processes, and is suggested to
be decisive in host range restriction [19,20,21](see Appendix S1,
Protein selection for 2009 A(H1N1)). Since several epitopes on
NPs have been found to be associated with the escape from human
cytotoxic T lymphocytes(CTLs), NPs are believed to prevent viral
replication from the attack of the host immune system [22,23].
The NP structure is an important feature that determines the
reservoir of a virus [21], for example, in a region where T-cell
recognizes. A conformational conversion means an altered/new
target in immunology, which can result in an alteration of the host
range potentially. Therefore, the overcoming of the species barrier
is also a case of CD. The switch region of structural change should
correspond to the sites significant in restricting host range. Based
on the high-quality theoretical analysis given by the present
Figure 3. The formation of H5N1 NS1 chain induced by local conformational conversion of residues around ED:R135. (A) NS1 chain
formed by the units shown in B [4]. In each unit, the ED of NS1 molecule interacts with each other, forming an ED dimer. The RBDs of each unit
interact with the RBDs and ED dimers of the neighbouring units. (B) Superposition of H5N1 NS1 dimer with the H1N1 NS1 ED dimer(in ruby; PDBID,
2GX9), demonstrating the twisting motion (curved arrows) of the H5N1 ED monomer, with respct to H1N1 ED. (C) Illustration of the predicted switch
region for H5N1 NS1(PDBID, 3F5T), shown in red and dots with central site R135. (D) The interchange probability for each residue site of full-length
H5N1 NS1 molecule. (E) A comparison of the crystallographic Ca atom deviations(A ˚) for H5N1 NS1 ED and H1N1 NS1 ED. There is notable structural
rearrangement around residue D134. Although a large structural fluctuation occurs at the N-terminal of H5N1 NS1 ED, which is also part of the
interface between RBD and ED dimer, it should not be responsible for the formation of NS1 chain because nearly identical structural rearrangement
also exists in the NS1 of low pathogenicity avian influenza virus H12N5(A/Duck/Albany/76; PDBID, 3D6R; The Ca atom deviations between
H12N5:3D6R and H5N1:3F5T are at most 3.5 A ˚ for these N-terminal residues), but induces no high pathogenicity. In A, the binding sites of RBD
induced by conformational conversion of ED are marked with red circles.
doi:10.1371/journal.pone.0008441.g003
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A(H1N1) in overcoming the species barrier, and discover the
reason of its high host population.
According to Figure 4A, there are two switch regions in NP
(S1[160–174], and S2[360–374]; analyzed by a homologue of the
NP of A/California/04/2009(H1N1), the sequence identity is
83%, PDBID_Chain: 2IQH_A). We searched the NCBI database
(http://www.ncbi.nlm.nih.gov, using blast tool [24]), and found
that segment S1 of virus 2009 A(H1N1) has been expressed by
various strains (including human host) for many years. The current
outbreak might not be due to the invalidation of the human
immune system against the segment. Therefore, S1 might not be
responsible for the present host range alteration. On the contrary,
segment S2 of virus 2009 A(H1N1) was only expressed by strains
of avian and swine flu viruses, but never in the human strain
before the current outbreak, that is, a novel target for the human
immune system could potentially arouse host alteration.
Actually, for residues around the switch region S2, the
experimental evidence for the key role of host restriction is quite
prominent. In virology, the protein has some phylogenetically
important regions (PIRs), which are believed to be important in
host selection and are considered host-specific functional regions of
the NP. As shown in Figure 4A, three out of six PIRs are around
switch region S2, which is also the only region where multiple host
types are related (human, swine, avian, and equine) [25].
Therefore, the map from the switch region of conformational
conversion, with positions belonging to S2 in particular, to
significant sites of host restriction is quite a success, although we
still cannot illustrate the host type in the above analysis (Here, we
only focused on segment position, but not the sequence details. See
the following paragraph for such details.).
For the novel influenza virus, the human host type is caused by a
special feature of segment S2. Because the segment belongs to the
most significant region for host restriction, the host becomes very
sensitive to residue details in S2. Therefore, the special segment
TRGVQIASNENVETM of the 2009 A(H1N1) S2 is vital, that is, a
detailed analysis of its human reservoir property is needed.
Although the segment mainly exists in strains of avian and swine
flu virus, it has the capability to be expressed in human strains. (The
fact has been observed in the current outbreak.) As evidence, all
single point mutations of this segment, the nearest homologues in
the NCBI database have been expressed by different human strains
(The details are shown in Table S1 in Appendix S1). Thus, this
segment essentially belongs to the human strain, and the current
alteration to the human host type is reasonable.
A potential mechanism of the 2009 A(H1N1)virus in overcoming
the species barrier has been illustrated. Most viruses that express the
segment TRGVQIASNENVETM belong to swine/avian strains.
While the 2009 A(H1N1) virus is predisposed to human host, there
should be certain factor that alter the preference and induce the
virus to become human strain. As shown in Table S1 of Appendix
S1, the human host mutations are on the C-terminal residues of S2,
that is, a PIR [25]. According to the three-dimensional protein
structure shown in Figure 4C, these residues adhere most tightly to
segment ‘a’ GPIYRRVDGKWMREL 94–108, which is also prone
to arouse conformational conversion and is mainly expressed by
strains of the human host. The human dominant segment ‘a’ can
induce S2 to be human specific, that is, the cooperation of structural
conversions between ‘a’ and S2 is a potential inducement
mechanism. As a coincidence, there is not a joint segment of ‘a’
and S2, GPIYRRVDGKWMREL-TRGVQIASNENVETM, in
the NCBI database before the present outbreak. This implies that
the human-specific alteration might be due to a new combination,
whichinducesthe structural conversionofS2by adheringa human-
dominant residue segment ‘a’.
Another dangerous feature of 2009 A(H1N1) is the lack of
knowledge why so many people have been infected by the virus.
Virus infection can induce the T cell-mediated immunity in the
host, which targets the highly conserved internal proteins of the
virus, such as M1, NP, and PB1 [26]. As a result, most healthy
human adults possess immunological memory against the influenza
virus due to the exposure to seasonal human influenza viruses. For
example, a segment similar to the S2 of the 2009 A(H1N1) virus can
inducetheimmunoreactionofmemoryT cellthroughepitopessuch
as ‘‘KLSTRGVQIASNEN’’ 357–370 (this epitope is taken from the
A/Puerto Rico/8/34(H1N1) strain[27],has11 residues identical to
those of the S2 of 2009 A(H1N1) NP). As shown in Table S1 of
Appendix S1, single-point mutants of S2 of the 2009 A(H1N1) virus
have been expressed in some classical human strains. Most of the
corresponding A(H1N1) strains, such as A/New Jersey/8/
1976(H1N1), A/Brevig Mission/1/1918(H1N1), and A/Puerto
Figure 4. Contribution of NP in overcoming species barrier for
the 2009 A(H1N1) virus. (A) The interchange probability for each
residue site of NP(PDBID, 2IQH_A). S1 and S2 are double switch regions.
Phylogenetically important regions are shown in purple. (B) Coverage of
epitope regions for memory T cell immune responses. Residues
involved in the epitope regions reported by ref. [26] are assigned value
1 (true), and 0 (false) otherwise. Except S2, all peak segments contain
residues involved in epitope regions of healthy individuals (epitopes are
observed from 90 persons in total). The epitope data are credible
because they are obtained by systemic ex vivo experimential analysis of
the influenza A virus-specific memory T cell responses (H5N1).
Moreover, data from an independent research group coincide with
them (H3N2, data not shown). (C) Structure of NP where segments are
colored as those in A. As a marker, residue 371 at the C-terminal of S2 is
shown in bulk. The C-terminal of S2 and the human host segment ‘a’ are
tightly adhered.
doi:10.1371/journal.pone.0008441.g004
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been infected by these viruses may be immunocompetent against
the present virus through epitopes related to S2. There is not such
immunological memory for people who have never met such
epitopes. Because viruses whose S2 is similar to that of 2009
A(H1N1) have been silent for a long time, many healthy individuals
have no immunological memory against S2 due to the lack of
exposure (as these have not globally prevailed for a long time). In
many healthy adults(Figure 4B), there is no epitope corresponding
to residues in the region around S2, such that there is no memory T
cell-mediated response to segment S2 of the 2009 A(H1N1) NP.
Thismaybe the cause of the large host populationand the tendency
of infection in young people. Since correlating with several typical
global pandemics (Table S1), segment S2 is extremely important for
host range restriction, and is a common feature of pandemic flu.
Methods
Our method is based on the assumption that the site responsible
for the initial pathogenic structural change in a CD likely belongs
to a segment related to the double-aspect nodes of the GPR.
Namely, some of the edges emanating from a double-aspect node
connect directly to the helix-donut zone, while others connect to
the strand-arc zone. Based on this idea, for each segment of a
query protein, we can find a set of its homologues in the nodes of
the GPR. Since they have similar biological properties, the set of
homologues can be deemed to be ‘copies’ of the query polypeptide
in the universe of polypeptides characterized by the GPR.
Information on the initiation site can be deduced from the
double-aspect degree, which is evaluated from the connections of
this set of nodes. The algorithm comprises three steps.
1. Identify Remote Homologues of the Query
Polypeptide in the GPR
Our analysis is based on the GPR, from which a database~ C was
constructed. Each node of the GPR acts as an entry heading, and is
assigned an entry index. The second part of an entry contains
indices of nodes that are directly connected to the node labelled as
the entry heading by one edge in the GPR. Consequently, in
database~ C, each node C of the GPR was mapped to an entry in the
form ‘ Index, C; Indexhomologue1, Indexhomologue2, Indexhomologue3 ...’.
A query protein is treated as successive residue segments. As the
residue–residue correlation is notable in 15-residue segments [28],
we used a window width of 15 for further consideration. By sliding
a 15-residue window along the protein sequence, each segment of
the query protein serves as a query polypeptide. Using the method
described in Section 2.1 of reference [10], we searched for remote
homologues (RHs) of the query polypeptide in set {C}. Multiple
features were investigated for this search algorithm, such as low
level of sequence identity (v26.7%), high levels of similarities in
sequence, three-dimensional structure, and surface residue distri-
bution. Only segments with a credible relationship to a query
polypeptide were collected in the final RH set. This led to a set of
RHs fC
RH1
i ,C
RH2
i ,C
RH3
i ,...g for each query polypeptide i, where a
query polypeptide is indexed by its central residue i. Each member
of this set corresponds to an entry in the database~ C. Then, a set of
entries related to query polypeptide i was obtained:
Index, C
RH1
i ; Indexhomologue1, Indexhomologue2, Indexhomologue3,...
Index, C
RH2
i ; Indexhomologue1, Indexhomologue2, Indexhomologue3,...
Index, C
RH3
i ; Indexhomologue1, Indexhomologue2, Indexhomologue3,...
:::
ð1Þ
2. Evaluate the Opportunity for Interchange between the
Helix-Donut and Strand-Arc Zones
For each query polypeptide, we evaluated its propensity for
structural change using information for the entries obtained in the
first step. For a 15-residue polypeptide, we can define subsegment
alalz1alz2alz3alz4alz5alz6 (l =0 or 8) to be in state H if more
than three residues are in a helix conformation, in state E if more
than three residues are in a strand conformation, and in state C
otherwise. Consequently, nine states are defined: HH, HC, CH,
EE, EC, CE, HE, EH, and CC. Figure 2 shows that nodes of
HHzHCzCH correspond to the main body of the helix-donut,
and nodes of EEzECzCE are largely in the strand-arc zone.
Thus, we can deduce the position of a segment in the polypeptide
phase space from its secondary structure. We assumed that
samples in HHzHCzCH belong to the helix-donut zone,
whereas those in EEzECzCE are in the strand-arc.
For a query polypeptide i, we evaluated the probability of
belonging to the two zones by node indicated by the indices in the
second parts of the entries in Eq. (1). Polypeptides indicated by
these indices were collected as set fWig for each query polypeptide
i. Using information on these correlative polypeptides, we can
evaluate the probability of query polypeptide i being in zone s as:
Pi(s)~Sn
j d(s,s’(wij))=n, where n is the size of set fWig, wij is a
member of set fWig with index j, s’(wij)~0 if wij belongs to
HHzHCzCH and s’(wij)~1 if wij is in EEzECzCE, and
d(x,y) is a step function with d(x,y)~1 for x~y and d(x,y)~0
otherwise. s~0 corresponds to the helix-donut zone, and s~1 to
the strand-arc zone.
In our viewpoint, every query polypeptide has the opportunity
to be either in the helix-donut zone or in the strand-arc zone, or in
the other zones. Information provided by the structure in hand is
only related to one state of a query polypeptide. There is
opportunity to jump to other states. Because the donut-arc part
contains nearly entire nodes of GPR, an investigation of the
interchange between the two zones will be representative and
accurate enough. For query polypeptide i, the probability of
interchange between a helix-donut and a strand-arc zone can be
evaluated as,
Qi~
(1{Pi{1(0))Pi(1)(1{Piz1(0)), if i is inHHzHCzCH,
jump to strand{arc:
(1{Pi{1(1))Pi(0)(1{Piz1(1)), if i is inEEzECzCE,
jump to helix{donut:
0, if i is others,
8
> > > > > > > > <
> > > > > > > > :
ð2Þ
where 1{Pj(s) denotes the probability that segment j is not in
state s. It is reasonable that a polypeptide with a higher
interchange probability is more prone to drifting into the structural
change related to a CD.
3. Filter of Conformational Changes Allowable under
Normal Conditions
Due to thermal motion, a protein has a normally flexible
structure that continually changes at room temperature. Helices
and strands can extend or shrink to a moderate degree. Such
structural conversion is vital for the biological functions of protein
molecules. For a segment with both helix and b-sheet conforma-
tions, the two types of secondary structure are interchangeable
under normal conditions. Such facile extension/shrinking of the
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the species would have been lost during evolution [8]. Therefore,
the corresponding sites are likely not responsible for CD, and
should not be included in our analysis. We extended a query
polypeptide by x residues (the empirically recommended param-
eter is x~4, i.e., approximately the period for a helix) on both
sides, and investigated whether both a helix and sheet existed in
such an enlarged window. Query polypeptides coinciding with this
condition were filtered, that is, the corresponding Qi was set to 0.
Polypeptides with a high value of Qi were predicted to be switch
sites for structural changes in the query protein corresponding
to CD.
The universality of an algorithm is usually proven by analyzing
proteins with low sequence identity to those in the learning set. For
any input query protein, our algorithm complies with this
requirement. In step 1, only segments with sequence identity of
less than 26.7% were collected in the RH set. In this way, query
data were removed from the prediction process. Moreover, in step
2, samples in set Wi share less than 26.7% sequence identity with
those in the RH set. After two approaches to remove redundant
data, segments used to calculate the interchange probability were
quite different from the query segment. Therefore, the algorithm is
an inborn cross validation for any query proteins.
Since the algorithm is based on remote homologues, the region
identified should be the same for all members of the corresponding
protein family. Thus, there is no strict requirement for the protein
structure that needs to be input. The structure of either the protein
of interest or its homologues can be used to obtain results for the
corresponding protein family.
To ensure a healthy development of modern biology, a patent is
applied for corresponding method. We encourage pure scientific
research. Contact authors when the method is to be used.
Supporting Information
Appendix S1 Some details about the algorithm, results and
A(H1N1)2009 flu.
Found at: doi:10.1371/journal.pone.0008441.s001 (2.73 MB
PDF)
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